E Fund Management Co., Ltd. Legend Biotech Corp Transaction History
E Fund Management Co., Ltd.
- $1.97 Billion
- Q4 2024
A detailed history of E Fund Management Co., Ltd. transactions in Legend Biotech Corp stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 113,322 shares of LEGN stock, worth $3.86 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
113,322
Previous 116,745
2.93%
Holding current value
$3.86 Million
Previous $5.69 Million
35.18%
% of portfolio
0.19%
Previous 0.3%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$255 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$232 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$204 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$195 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$194 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.7B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...